160 related articles for article (PubMed ID: 30231334)
1. State-of-the-Art Management of Germ Cell Tumors.
Feldman DR
Am Soc Clin Oncol Educ Book; 2018 May; 38():319-323. PubMed ID: 30231334
[TBL] [Abstract][Full Text] [Related]
2. Contemporary management of postchemotherapy testis cancer.
Daneshmand S; Albers P; Fosså SD; Heidenreich A; Kollmannsberger C; Krege S; Nichols C; Oldenburg J; Wood L
Eur Urol; 2012 Nov; 62(5):867-76. PubMed ID: 22938868
[TBL] [Abstract][Full Text] [Related]
3. The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
Dash A; Carver BS; Stasi J; Bajorin DF; Motzer RJ; Bosl GJ; Sheinfeld J
Cancer; 2008 Feb; 112(4):800-5. PubMed ID: 18172902
[TBL] [Abstract][Full Text] [Related]
4. Management of germ cell tumors in children: approaches to cure.
Göbel U; Calaminus G; Schneider DT; Schmidt P; Haas RJ;
Onkologie; 2002 Feb; 25(1):14-22. PubMed ID: 11893878
[TBL] [Abstract][Full Text] [Related]
5. Management of advanced germ-cell tumors of the testis.
Fléchon A; Rivoire M; Droz JP
Nat Clin Pract Urol; 2008 May; 5(5):262-76. PubMed ID: 18398406
[TBL] [Abstract][Full Text] [Related]
6. Management of low-stage nonseminomatous germ cell tumors of testis: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009.
Stephenson AJ; Aprikian AG; Gilligan TD; Oldenburg J; Powles T; Toner GC; Waters WB
Urology; 2011 Oct; 78(4 Suppl):S444-55. PubMed ID: 21986224
[TBL] [Abstract][Full Text] [Related]
7. Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor.
Miki T; Mizutani Y; Akaza H; Ozono S; Tsukamoto T; Terachi T; Naito K; Nonomura N; Hara I; Yoshida O;
Int J Urol; 2007 Jan; 14(1):54-9. PubMed ID: 17199861
[TBL] [Abstract][Full Text] [Related]
8. [CCAFU french national guidelines 2016-2018 on testicular germ cell tumors].
Durand X; Fléchon A; Murez T; Rocher L; Camparo P; Morel-Journel N; Savoie PH; Ferretti L; Sèbe P; Méjean A
Prog Urol; 2016 Nov; 27 Suppl 1():S147-S165. PubMed ID: 27846929
[TBL] [Abstract][Full Text] [Related]
9. Multimodal treatment of malignant sacrococcygeal germ cell tumors: a prospective analysis of 66 patients of the German cooperative protocols MAKEI 83/86 and 89.
Göbel U; Schneider DT; Calaminus G; Jürgens H; Spaar HJ; Sternschulte W; Waag K; Harms D
J Clin Oncol; 2001 Apr; 19(7):1943-50. PubMed ID: 11283126
[TBL] [Abstract][Full Text] [Related]
10. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
Pico JL; Fadel E; Ibrahim A; Bourhis JH; Droz JP
Bull Cancer; 1995; 82 Suppl 1():56s-60s. PubMed ID: 7542945
[TBL] [Abstract][Full Text] [Related]
11. Testicular germ cell tumors in boys <10 years: results of the protocol MAHO 98 in respect to surgery and watch & wait strategy.
Göbel U; Haas R; Calaminus G; Botorek P; Schmidt P; Teske C; Schönberger S; Schneider DT; Harms D
Klin Padiatr; 2013 Nov; 225(6):296-302. PubMed ID: 24158884
[TBL] [Abstract][Full Text] [Related]
12. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
13. Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.
Motzer RJ; Nichols CJ; Margolin KA; Bacik J; Richardson PG; Vogelzang NJ; Bajorin DF; Lara PN; Einhorn L; Mazumdar M; Bosl GJ
J Clin Oncol; 2007 Jan; 25(3):247-56. PubMed ID: 17235042
[TBL] [Abstract][Full Text] [Related]
14. Predictors of outcome in patients with advanced nonseminomatous germ cell testicular tumors.
Yetisyigit T; Babacan N; Urun Y; Seber ES; Cihan S; Arpaci E; Yildirim N; Aksoy S; Budakoglu B; Zengin N; Oksuzoglu B; Yalcin BC; Alkis N
Asian Pac J Cancer Prev; 2014; 15(2):831-5. PubMed ID: 24568504
[TBL] [Abstract][Full Text] [Related]
15. Management of Refractory Germ Cell Cancer.
Lorch A
Am Soc Clin Oncol Educ Book; 2018 May; 38():324-329. PubMed ID: 30231348
[TBL] [Abstract][Full Text] [Related]
16. Current outstanding challenges in germ cell tumors.
Salous T; Adra N
Curr Opin Oncol; 2024 May; 36(3):169-173. PubMed ID: 38573206
[TBL] [Abstract][Full Text] [Related]
17. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.
Aprikian AG; Herr HW; Bajorin DF; Bosl GJ
Cancer; 1994 Aug; 74(4):1329-34. PubMed ID: 8055456
[TBL] [Abstract][Full Text] [Related]
18. Conundrums in the management of malignant ovarian germ cell tumors: Toward lessening acute morbidity and late effects of treatment.
Gershenson DM; Frazier AL
Gynecol Oncol; 2016 Nov; 143(2):428-432. PubMed ID: 27569583
[TBL] [Abstract][Full Text] [Related]
19. Germ cell tumors of the ovary.
Pectasides D; Pectasides E; Kassanos D
Cancer Treat Rev; 2008 Aug; 34(5):427-41. PubMed ID: 18378402
[TBL] [Abstract][Full Text] [Related]
20. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
Carver BS; Shayegan B; Eggener S; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
J Clin Oncol; 2007 Oct; 25(28):4365-9. PubMed ID: 17906201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]